On 23 February, the European Commission’s Innovation Radar published the PROMINENT innovation “Patient-centered diagnostic summary reports for dementia care” on its public platform, recognising Alzheimer Europe as a key innovator in its development.
The innovation focuses on structured, patient-centred diagnostic summary reports designed to improve how diagnostic information in dementia care is communicated and used in clinical practice. By presenting results in a clearer and more accessible format, the reports aim to support clinicians, people with dementia and their families in understanding complex diagnostic information and facilitating shared decision-making.
According to the Innovation Radar assessment, the innovation is at an “Exploring” stage of market maturity and addresses the needs of existing markets and existing customers. The listing also recognises the innovation as women-led, as a woman held a leadership role in its development within at least one of the key innovator organisations. Identified go-to-market needs include preparing for market entry and scaling up market opportunities.
The innovation was developed within the Innovative Medicines Initiative funded PROMINENT consortium together with COMBINOSTICS OY (Tampere, Finland), a small or medium-sized enterprise, and Klinikum der Universität zu Köln (Cologne, Germany), a higher education and research institution. All three organisations are listed as key innovators for this solution.
The Innovation Radar entry is available here:
https://innovation-radar.ec.europa.eu/innovation/65103
